Welcome to Science News coverage of AHA's Scientific Sessions 2017 in Anaheim, California. This is where you'll find details on some of the most noteworthy presentations this year, along with exclusive interviews with presenting investigators, clinical experts, and AHA volunteers.

Saturday, Nov. 11

Program Highlights: Scientific Sessions 2017

Eric Peterson, MD, program chair for Scientific Sessions 2017, and Don Lloyd-Jones, MD, ScM, program vice chair, review the highlights of the clinical science planned for the meeting in Anaheim.

Welcome to Scientific Sessions 2017

John Warner, MD, president of the American Heart Association, welcomes members to Scientific Sessions 2017 in Anaheim.

Resuscitation Science Symposium - Best Oral Abstract Presentations and Presentation of the Best Abstract Awards for Cardiac and Trauma Resuscitation Science

PRESERVERESULTS: For AF patients on NOAC anticoagulants having device surgery, there was no real difference for continuing vs stopping NOAC’s for surgery; trial stopped early because of low event rates for both arms.

Monday, Nov. 13

Paul M. Ridker, MD provides an overview of the results of the CANTOS trial.

SPRINT

Karen C. Johnson relates the results of the SPRINT trial.

GATEWAY

Carlos A. Schiavon, MD, PhD provides an overview of the results of the GATEWAY trial.

REAL CAD

Sidney C. Smith, Jr, MD, past-president of the American Heart Association, discusses the results of REAL-CAD.

BP TITRE

Sidney C. Smith, Jr, MD, past-president of the American Heart Association, discusses the results of the BP TITRE trial.

Understanding the 2017 Hypertension Guidelines

John Warner, MD, president of the American Heart Association, interviews Paul Whelton, MD, writing group chair for the 2017 Hypertension Clinical Practice Guidelines and the need for the guidelines, the new classification system, and what it means for clinicians and their patients. Read the guidelines, resources, and complete coverage.

Strategies for Adherence to Treatments for Hypertension

Dan W. Jones, MD, past-president of the American Heart Association, and Paul Whelton, MD, chair of the writing group for the 2017 Hypertension Clinical Practice Guidelines discuss strategies for adherence to treatments for hypertension. Read the guidelines, resources, and complete coverage.

Dan W. Jones, MD, past-president of the American Heart Association, and Paul Whelton, MD, writing group chair, discuss the prevalence of hypertension as defined by the 2017 Hypertension Clinical Practice Guidelines.

Late Breaking Clinical Trials 5: New Insights into the Risks, Benefits, and Costs of Antithrombotic Therapy

SWEDEHEARTRESULTS: Over the past 20 years, as evidence-based treatments for NSTEM patients were implemented, long-term survival has improved and the risk for new CV events and HF has improved. (Swedish study)

STIC2ITRESULTS: Tele-pharmacy Intervention improved adherence to medication, but did not improve clinical outcomes.

ACS QUIKRESULTS: In this Indian population, the quality improvement toolkit improved process measures (in-hospital and discharge medications), but did not improve the 30-day MACE rates compared to usual care.

iCARE-ACSRESULTS: An ED tool used to assess ACS in 7 New Zealand hospitals increased the number of patients safely discharged within 6 hours.

DECIDE-LVADRESULTS: A DT LVAD decision support tool improved the quality of decisions with more alignment between the value of the treatment and the patient’s wishes.

STEMI ACCELERATOR-2RESULTS: Improvements in regional systems of care was associated with significant reduction in time to STEMI reperfusion, as well as in-hospital mortality.

Eldrin Lewis, MD, MPH interviews Early Career Bloggers Annie Roessler, Baily De Barmore, and Shayan Mohammadmoradi about their experiences at Scientific Sessions 2017. Read their posts and other bloggers in the Early Career Voice.

The Patient Perspective

Early Career Blogger Bailey DeBarmore talks to heart transplant recipient Leilani Graham about the patient perspective on Scientific Sessions 2017.

New Treatment Approaches for Hypertension

Dan W. Jones, MD, past-president of the American Heart Association, and Paul Whelton, MD, writing group chair, discuss the implications of the 2017 Hypertension Clinical Practice Guidelines for treating patients at various levels of risk.

Managing Hypertension in Patients with Comorbidities

Dan W. Jones, MD, past-president of the American Heart Association, and Robert Carey, MD, writing group co-chair, discuss the implications of the 2017 Hypertension Clinical Practice Guidelines for patients with the comorbidities of diabetes and chronic kidney disease.